Streetbeat News

Price Targets

NVDA

BofA analysts have maintained a Buy rating and a $700 per share price target for NVIDIA (NASDAQ:NVDA), citing the company's potential to generate approximately $100 billion in free cash flow (FCF) in CY24/25E. They believe NVIDIA's dominance in generative AI could drive this significant FCF, which could lead to both organic and inorganic growth opportunities. While they estimate $30-$35 billion could be used for buybacks, the remaining $65-$70 billion could fund new initiatives. The analysts also note NVIDIA's current trading multiple is depressed compared to its historical median, attributing this to uncertainties in CY25 growth prospects and its hardware-dependent business model. They suggest that NVIDIA's strong FCF generation provides the flexibility to address these concerns and potentially increase its trading multiple by building a recurring revenue profile.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 4:56 pm

VTEX

VTEX stock has seen a positive movement after Morgan Stanley upgraded the stock from Equal-Weight to Overweight and increased the price target from $5.5 to $8.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 4:50 pm

DNB

Dun & Bradstreet Holdings' stock (DNB) has seen an uptick in trading after Raymond James upgraded the stock from Outperform to Strong Buy, with a new price target set at $18.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 4:17 pm

AGL

JP Morgan analyst Lisa Gill has downgraded Agilon Health (NYSE:AGL) from Overweight to Neutral and reduced the price target from $17 to $9.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 4:15 pm

CYT

B of A Securities analyst Tazeen Ahmad has downgraded Cyteir Therapeutics (NASDAQ:CYT) from Neutral to Underperform and set a price target of $3. This downgrade suggests a bearish outlook on the company's stock by the analyst.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 4:14 pm

OMC

Macquarie analyst Tim Nollen has upgraded Omnicom Group (NYSE:OMC) from Neutral to Outperform and increased the price target from $80 to $100.

Portfolio Pulse from Benzinga Newsdesk

January 05, 2024 | 4:06 pm

EGLE

Eagle Bulk Shipping (NYSE:EGLE) has received mixed analyst ratings over the past three months, with 2 bullish and 2 indifferent ratings. The average 12-month price target is now $53.3, down from $64.00, indicating a 16.72% decrease. Analysts from Noble Capital Markets, B. Riley Securities, Jefferies, and Stifel have provided recent evaluations, with some maintaining and others lowering their price targets. Eagle Bulk Shipping's financial health shows challenges, with a -55.42% revenue decline, below-average net margin, ROE, and ROA, and a high debt-to-equity ratio of 0.85.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 4:01 pm

DT

Dynatrace (NYSE:DT) has been analyzed by 6 analysts, showing a positive sentiment with 5 bullish and 1 somewhat bullish ratings. The 12-month price targets have an average of $62.5, with a high of $70 and a low of $58, marking a 13.64% increase from the previous average of $55. Analysts have adjusted their ratings and price targets, reflecting their response to recent developments. Dynatrace's financial health indicators show a lower market cap, high revenue growth of 25.91%, exceptional net margin of 10.18%, but lower ROE and ROA compared to industry benchmarks, and a conservative debt-to-equity ratio of 0.04.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 4:01 pm

NCLH

Analysts have provided mixed reviews on Norwegian Cruise Line (NYSE:NCLH) with 9 different ratings over the last three months. The average 12-month price target is now $18.17, down from $20.50, with a high estimate of $32.00 and a low of $13.50. Several analysts have lowered their price targets and ratings, reflecting a cautious outlook on the company's financial performance, which includes strong revenue growth but concerns over net margin, ROA, and high debt levels. Norwegian Cruise Line's ROE is notably high at 152.4%, indicating efficient use of equity capital.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 4:01 pm

ALLY

Ally Financial (NYSE:ALLY) has received mixed analyst ratings over the past quarter, with 9 analysts offering diverse opinions. The average 12-month price target is $33.67, with a recent decrease of 0.47%. Analysts from firms like Barclays, Goldman Sachs, and Morgan Stanley have updated their ratings and price targets, reflecting changes in market conditions and company performance. Ally Financial's market capitalization is below industry average, and it has seen a revenue decline of -1.41% over the past 3 months. The company's net margin is strong at 12.38%, but ROE and ROA are below industry standards. Ally Financial's debt-to-equity ratio is conservative at 2.08.

Portfolio Pulse from Benzinga Insights

January 05, 2024 | 4:00 pm